If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Retevmo ® (selpercatinib) capsules
40 mg, 80 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
RETEVMO™ (selpercatinib): Patient Copay Assistance
Assistance is available to qualified patients in paying for their medication.
Please visit https://www.lillyoncologysupport.com or call 1-866-472-8663, Monday through Friday, 8 AM to 10 PM ET.
Date of Last Review: May 14, 2020